Related Experiment Video
Updated: Oct 24, 2025

Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst
Published on: March 31, 2023
Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis
Angelo Zinellu1, Arduino A Mangoni2,3
1Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Insights
Higher serum cystatin C levels indicate increased coronavirus disease 19 (COVID-19) severity and mortality risk. This marker aids in stratifying patients and guiding clinical decisions for better COVID-19 management.
Area of Science:
- Biochemistry
- Clinical Medicine
- Epidemiology
Background:
- Coronavirus disease 19 (COVID-19) poses significant clinical challenges.
- Markers of renal dysfunction and inflammation, such as cystatin C, may aid in risk stratification for COVID-19 patients.
Purpose of the Study:
- To systematically review and meta-analyze the association between serum cystatin C concentrations and clinical outcomes in COVID-19 patients.
Main Methods:
- A systematic literature search was conducted in PubMed, Web of Science, and Scopus (January 2020 - February 2021).
- Included studies reported serum cystatin C levels, clinical severity, and survival outcomes in hospitalized COVID-19 patients.
- Meta-analysis and meta-regression were performed on data from 13 studies involving 2510 patients.
Main Results:
- Higher serum cystatin C concentrations were significantly associated with increased COVID-19 disease severity and non-survivor status (SMD 1.71, p < 0.001).
- Extreme heterogeneity was noted across studies (I² = 97.5%), but sensitivity analyses confirmed the robustness of the findings.
- Meta-regression revealed no association between serum cystatin C levels and various demographic or laboratory parameters, including age, sex, or common comorbidities.
Conclusions:
- Elevated serum cystatin C levels are a strong indicator of higher severity and mortality in COVID-19 patients.
- Serum cystatin C shows potential as a valuable biomarker for risk stratification and clinical decision-making in COVID-19 management.
Background:
Combined markers of renal dysfunction and inflammation, e.g., cystatin C, might assist with risk stratification and clinical decisions in patients with coronavirus disease 19 (COVID-19). We conducted a systematic review and meta-analysis with meta-regression of serum cystatin C in COVID-19.
Methods:
We searched PubMed, Web of Science and Scopus, between January 2020 and February 2021, for studies reporting serum cystatin C concentrations, measures of clinical severity and survival outcomes in hospitalized COVID-19 patients (PROSPERO registration number: CRD42021245295).
Results:
Thirteen studies in 2510 COVID-19 patients, 1972 with low severity or survivor status and 538 with high severity or non-survivor status during follow up, were included in the meta-analysis. The pooled results showed that serum cystatin C concentrations were higher in patients with high disease severity or non-survivor status (standard mean deviation, SMD, 1.71, 95% CI 0.95 to 2.46, p < 0.001). Extreme between-study heterogeneity was observed (I2 = 97.5%, p < 0.001). Sensitivity analysis, performed by sequentially removing each study and re-assessing the pooled estimates, showed that the magnitude and direction of the effect size was not substantially modified. The Begg's and Egger's t tests did not show publication bias. In meta-regression, the SMD of serum cystatin C was not associated with age, proportion of males, C-reactive protein, neutrophils, lymphocytes, aspartate aminotransferase, alanine aminotransferase, albumin, creatinine, creatine kinase-MB, lactate dehydrogenase, and proportion of patients with diabetes or hypertension.
Conclusions:
Higher concentrations of serum cystatin C were associated with higher COVID-19 severity and mortality.
More Related Videos
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
19:16The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Single Nucleotide Polymorphisms-SNPs
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT